PTX 0.00% 4.5¢ prescient therapeutics limited

updated chart, page-733

  1. 3,872 Posts.
    lightbulb Created with Sketch. 3205
    Also I'd say Steven is a little more than purely a banker.

    Bit of a heavy hitter in my opinion for a Biotechnology CEO, not many would have that crucial diversity which potentially makes him a match made in heaven. The marriage of economic and biochemistry degrees, invaluable to PTX shareholders. You have to give credit when credit is due, his education/resume speaks for itself.

    "Steven holds a Bachelor of Science with an Honours Degree in Biochemistry and Molecular Biology, and a Bachelor Commerce majoring in Economics, both from the University of Melbourne. He has been a collaborator on various immunotherapy research projects."
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.000(0.00%)
Mkt cap ! $36.23M
Open High Low Value Volume
4.5¢ 4.5¢ 4.3¢ $36.04K 810.4K

Buyers (Bids)

No. Vol. Price($)
1 20000 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 974 1
View Market Depth
Last trade - 13.57pm 04/10/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.